Your browser doesn't support javascript.
loading
Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in n-Dimensions (SHY-n): Identification of Potential Cardiovascular Risk Biomarkers Related to SARS-CoV-2 Infection.
Masuda, Reika; Lodge, Samantha; Whiley, Luke; Gray, Nicola; Lawler, Nathan; Nitschke, Philipp; Bong, Sze-How; Kimhofer, Torben; Loo, Ruey Leng; Boughton, Berin; Zeng, Annie X; Hall, Drew; Schaefer, Hartmut; Spraul, Manfred; Dwivedi, Girish; Yeap, Bu B; Diercks, Tammo; Bernardo-Seisdedos, Ganeko; Mato, José M; Lindon, John C; Holmes, Elaine; Millet, Oscar; Wist, Julien; Nicholson, Jeremy K.
Affiliation
  • Masuda R; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Lodge S; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Whiley L; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Gray N; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Lawler N; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Nitschke P; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Bong SH; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Kimhofer T; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Loo RL; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Boughton B; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Zeng AX; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Hall D; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Schaefer H; Bruker Biospin GmbH, Silberstreifen, Ettlingen 76275, Germany.
  • Spraul M; Bruker Biospin GmbH, Silberstreifen, Ettlingen 76275, Germany.
  • Dwivedi G; Department of Cardiology, Fiona Stanley Hospital, Medical School, University of Western Australia, Perth 6150, Western Australia, Australia.
  • Yeap BB; Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Medical School, University of Western Australia, Perth 6150, Western Australia, Australia.
  • Diercks T; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Parque Tecnológico de Bizkaia, Bld. 800, 48160 Derio, Spain.
  • Bernardo-Seisdedos G; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Parque Tecnológico de Bizkaia, Bld. 800, 48160 Derio, Spain.
  • Mato JM; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Parque Tecnológico de Bizkaia, Bld. 800, 48160 Derio, Spain.
  • Lindon JC; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K.
  • Holmes E; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
  • Millet O; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K.
  • Wist J; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Parque Tecnológico de Bizkaia, Bld. 800, 48160 Derio, Spain.
  • Nicholson JK; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.
Anal Chem ; 94(10): 4426-4436, 2022 03 15.
Article de En | MEDLINE | ID: mdl-35230805
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / COVID-19 Type d'étude: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Humans Langue: En Journal: Anal Chem Année: 2022 Type de document: Article Pays d'affiliation: Australie Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / COVID-19 Type d'étude: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Humans Langue: En Journal: Anal Chem Année: 2022 Type de document: Article Pays d'affiliation: Australie Pays de publication: États-Unis d'Amérique